NCT02904538

Brief Summary

Both perineural and systemic dexamethasone administration allows an increase in analgesic duration of regional anesthesia. There is a lack of data to determine wich route allows a longer analgesic effect. This study aims to determine wether perineural dexamethasone allows a longer analgesic duration than systemic route in combination with regional anesthesia (Ropivacaine 0.375%) for front foot surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Nov 2016

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 19, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

November 22, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 23, 2017

Completed
Last Updated

June 16, 2017

Status Verified

June 1, 2017

Enrollment Period

6 months

First QC Date

September 6, 2016

Last Update Submit

June 15, 2017

Conditions

Keywords

DexamethasoneRegional anesthesiaFront foot surgeryMetacarpal osteotomy

Outcome Measures

Primary Outcomes (1)

  • time to the first opioids request

    during the first 48 hours

Secondary Outcomes (3)

  • occurrence of nausea or vomiting

    at day 1

  • overall satisfaction regarding pain relief management

    at day 1

  • any significant side effects

    during the first 7 days after surgery.

Study Arms (2)

Perineural group

EXPERIMENTAL

1cc (4mg) of dexamethasone will be administrated in perineural injection. 2.5cc of isotonic saline solution will be administrated in systemic injection.

Drug: Dexamethasone

systemic group

EXPERIMENTAL

1cc of isotonic saline will be administrated in perineural injection. 2.5cc (10mg) of dexamethasone will be administrated in systemic injection.

Drug: DexamethasoneDrug: isotonic saline

Interventions

Perineural groupsystemic group
systemic group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • front foot surgery with metacarpal osteotomy under regional anesthesia
  • \>18 years old
  • consent to participate in the study

You may not qualify if:

  • refusal to participate
  • pregnancy
  • feeding
  • pre existing neuropathy
  • ropivacaine allergy
  • paracetamol allergy
  • liver failure
  • cardiac failure
  • ketoprofen allergy
  • gastric ulcer within the previous year
  • tramadol allergy
  • history of epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

Location

Related Publications (1)

  • Marty P, Rontes O, Chassery C, Vuillaume C, Basset B, Merouani M, Marquis C, Bataille B, Chaubard M, Mailles MC, Ferre F, Delbos A. Perineural Versus Systemic Dexamethasone in Front-Foot Surgery Under Ankle Block: A Randomized Double-Blind Study. Reg Anesth Pain Med. 2018 Oct;43(7):732-737. doi: 10.1097/AAP.0000000000000769.

MeSH Terms

Interventions

DexamethasoneSodium Chloride

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Jean-Michel CONSTANTIN

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2016

First Posted

September 19, 2016

Study Start

November 22, 2016

Primary Completion

May 23, 2017

Study Completion

May 23, 2017

Last Updated

June 16, 2017

Record last verified: 2017-06

Locations